PKM2 抗体
(Pyruvate Kinase M2 (PKM2))
This gene encodes a protein involved in glycolysis. The encoded protein is a pyruvate kinase that catalyzes the transfer of a phosphoryl group from phosphoenolpyruvate to ADP, generating ATP and pyruvate. This protein has been shown to interact with thyroid hormone and may mediate cellular metabolic effects induced by thyroid hormones. This protein has been found to bind Opa protein, a bacterial outer membrane protein involved in gonococcal adherence to and invasion of human cells, suggesting a role of this protein in bacterial pathogenesis. Several alternatively spliced transcript variants encoding a few distinct isoforms have been reported. [provided by RefSeq, May 2011].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| PKM2 抗体 (AA 1-531) | 人 | 小鼠 Monoclonal |
|
|
|
| PKM2 抗体 (AA 436-531) | 人 | 小鼠 Monoclonal |
|
|
|
| PKM2 抗体 (AA 324-531) | 大鼠 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (N-Term) | 人, 小鼠, 大鼠 | 小鼠 Monoclonal |
|
|
|
| PKM2 抗体 (N-Term) | 人 | 小鼠 Monoclonal |
|
|
|
| PKM2 抗体 (N-Term) | 人, 小鼠, 大鼠 | 小鼠 Monoclonal |
|
|
|
| PKM2 抗体 (pThr45) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (AA 324-531) | 大鼠 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (AA 460-489) | 人 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (AA 121-151) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (Middle Region) | 人, 小鼠, 大鼠, 兔, Cow, 犬, 豚鼠, 马, Saccharomyces cerevisiae, 绵羊, 斑马鱼 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (AA 255-350) (PE) | 小鼠 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (AA 255-350) (AbBy Fluor® 680) | 小鼠 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (AA 255-350) (AbBy Fluor® 750) | 小鼠 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (AA 255-350) (Cy5.5) | 小鼠 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (AA 255-350) (Cy7) | 小鼠 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (AA 255-350) (Cy5) | 小鼠 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (AA 255-350) (FITC) | 小鼠 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (AA 255-350) (Biotin) | 小鼠 | 兔 Polyclonal |
|
|
|
| PKM2 抗体 (AA 255-350) (HRP) | 小鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 5D2-3B3
- 标记
- unconjugated
- 抗体亚型
- IgM kappa
- 抗原表位
- AA 1-531
Primary Antibody
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2D8
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 436-531
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 324-531
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- AFfirm8310
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- AFfirm8340
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- AFfirm8363
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pThr45
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 324-531
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 460-489
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 121-151
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, 兔, Cow, 犬, 豚鼠, 马, Saccharomyces cerevisiae, 绵羊, 斑马鱼
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 255-350
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 680
- 抗体亚型
- IgG
- 抗原表位
- AA 255-350
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 750
- 抗体亚型
- IgG
- 抗原表位
- AA 255-350
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5.5
- 抗体亚型
- IgG
- 抗原表位
- AA 255-350
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy7
- 抗体亚型
- IgG
- 抗原表位
- AA 255-350
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5
- 抗体亚型
- IgG
- 抗原表位
- AA 255-350
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 255-350
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 255-350
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 255-350
Latest Publications for our PKM2 抗体
: "A pathogen-derived effector modulates host glucose metabolism by arginine GlcNAcylation of HIF-1α protein." in: PLoS pathogens, Vol. 14, Issue 8, pp. e1007259, (2019) (PubMed).
: "Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling." in: Current cancer drug targets, Vol. 18, Issue 6, pp. 592-599, (2018) (PubMed).
: "Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression." in: Cell death & disease, Vol. 8, Issue 7, pp. e2944, (2018) (PubMed).
: "PKM2 promotes cell migration and inhibits autophagy by mediating PI3K/AKT activation and contributes to the malignant development of gastric cancer." in: Scientific reports, Vol. 7, Issue 1, pp. 2886, (2018) (PubMed).
: "A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells." in: International journal of molecular sciences, Vol. 18, Issue 1, (2017) (PubMed).
: "MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells." in: Oncotarget, Vol. 8, Issue 20, pp. 33064-33077, (2017) (PubMed).
: "Specific tumor-derived CCL2 mediated by pyruvate kinase M2 in colorectal cancer cells contributes to macrophage recruitment in tumor microenvironment." in: Tumour biology, Vol. 39, Issue 3, pp. 1010428317695962, (2017) (PubMed).
: "Enhanced aerobic glycolysis of nasopharyngeal carcinoma cells by Epstein-Barr virus latent membrane protein 1." in: Experimental cell research, Vol. 359, Issue 1, pp. 94-100, (2017) (PubMed).
: "MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1." in: Cancer science, Vol. 107, Issue 12, pp. 1767-1775, (2016) (PubMed).
: "Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer." in: Tumour biology, Vol. 37, Issue 6, pp. 8159-68, (2016) (PubMed).
: "Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling." in: Current cancer drug targets, Vol. 18, Issue 6, pp. 592-599, (2018) (PubMed).
: "Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression." in: Cell death & disease, Vol. 8, Issue 7, pp. e2944, (2018) (PubMed).
: "PKM2 promotes cell migration and inhibits autophagy by mediating PI3K/AKT activation and contributes to the malignant development of gastric cancer." in: Scientific reports, Vol. 7, Issue 1, pp. 2886, (2018) (PubMed).
: "A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells." in: International journal of molecular sciences, Vol. 18, Issue 1, (2017) (PubMed).
: "MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells." in: Oncotarget, Vol. 8, Issue 20, pp. 33064-33077, (2017) (PubMed).
: "Specific tumor-derived CCL2 mediated by pyruvate kinase M2 in colorectal cancer cells contributes to macrophage recruitment in tumor microenvironment." in: Tumour biology, Vol. 39, Issue 3, pp. 1010428317695962, (2017) (PubMed).
: "Enhanced aerobic glycolysis of nasopharyngeal carcinoma cells by Epstein-Barr virus latent membrane protein 1." in: Experimental cell research, Vol. 359, Issue 1, pp. 94-100, (2017) (PubMed).
: "MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1." in: Cancer science, Vol. 107, Issue 12, pp. 1767-1775, (2016) (PubMed).
: "Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer." in: Tumour biology, Vol. 37, Issue 6, pp. 8159-68, (2016) (PubMed).
Aliases for PKM2 抗体
pyruvate kinase M1/2 (PKM) 抗体pyruvate kinase, muscle (Pkm) 抗体
pyruvate kinase, muscle (PKM) 抗体
AA414905 抗体
AL024370 抗体
AL024424 抗体
CTHBP 抗体
OIP3 抗体
Pk-2 抗体
Pk-3 抗体
PK3 抗体
Pk3 抗体
PKM 抗体
PKM2 抗体
Pkm2 抗体
PKM12 抗体
TCB 抗体
THBP1 抗体
您还需要查找其他产品吗？
You are here:
